

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 6.20233292 |
| 2 | sequestering of actin monomers (GO:0042989) | 5.26052975 |
| 3 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.85078698 |
| 4 | phagocytosis, engulfment (GO:0006911) | 4.55122461 |
| 5 | granulocyte activation (GO:0036230) | 4.40781247 |
| 6 | regulation of chronic inflammatory response (GO:0002676) | 4.29208850 |
| 7 | negative regulation of vascular permeability (GO:0043116) | 4.24065728 |
| 8 | positive regulation of T cell apoptotic process (GO:0070234) | 4.20964550 |
| 9 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.10903994 |
| 10 | neutrophil activation (GO:0042119) | 3.93511176 |
| 11 | thrombin receptor signaling pathway (GO:0070493) | 3.88475007 |
| 12 | positive regulation of actin filament depolymerization (GO:0030836) | 3.85631267 |
| 13 | membrane invagination (GO:0010324) | 3.84439696 |
| 14 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.80010103 |
| 15 | negative regulation of lipid storage (GO:0010888) | 3.76833636 |
| 16 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.63124251 |
| 17 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.61499441 |
| 18 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.59687816 |
| 19 | eosinophil chemotaxis (GO:0048245) | 3.59006289 |
| 20 | negative regulation of T cell apoptotic process (GO:0070233) | 3.57682811 |
| 21 | regulation of immunoglobulin secretion (GO:0051023) | 3.52020301 |
| 22 | cell adhesion mediated by integrin (GO:0033627) | 3.47443876 |
| 23 | positive regulation of vascular permeability (GO:0043117) | 3.46493727 |
| 24 | actin nucleation (GO:0045010) | 3.42339765 |
| 25 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.39159581 |
| 26 | mitochondrial calcium ion transport (GO:0006851) | 3.38796556 |
| 27 | hemoglobin metabolic process (GO:0020027) | 3.38276667 |
| 28 | oligosaccharide catabolic process (GO:0009313) | 3.36086499 |
| 29 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.29360285 |
| 30 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.25740797 |
| 31 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.23955955 |
| 32 | response to muscle activity (GO:0014850) | 3.22802117 |
| 33 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.15758202 |
| 34 | eosinophil migration (GO:0072677) | 3.15236955 |
| 35 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.13883427 |
| 36 | regulation of T cell apoptotic process (GO:0070232) | 3.13109581 |
| 37 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.12680282 |
| 38 | regulation of mononuclear cell migration (GO:0071675) | 3.10610296 |
| 39 | monocyte chemotaxis (GO:0002548) | 3.04542605 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 3.02212327 |
| 41 | positive regulation of leukocyte apoptotic process (GO:2000108) | 3.00660044 |
| 42 | platelet dense granule organization (GO:0060155) | 2.99379593 |
| 43 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.92678596 |
| 44 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.91419405 |
| 45 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.90810383 |
| 46 | negative regulation of mast cell activation (GO:0033004) | 2.90037055 |
| 47 | cAMP catabolic process (GO:0006198) | 2.86429345 |
| 48 | cellular response to zinc ion (GO:0071294) | 2.85643701 |
| 49 | negative regulation of macrophage differentiation (GO:0045650) | 2.84500427 |
| 50 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.83821924 |
| 51 | protein localization to lysosome (GO:0061462) | 2.80498922 |
| 52 | protein localization to vacuole (GO:0072665) | 2.80498922 |
| 53 | positive regulation of lamellipodium assembly (GO:0010592) | 2.80481156 |
| 54 | substrate-dependent cell migration (GO:0006929) | 2.76254199 |
| 55 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.76186515 |
| 56 | regulation of thymocyte apoptotic process (GO:0070243) | 2.74879635 |
| 57 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.74445419 |
| 58 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.73852330 |
| 59 | positive regulation of heat generation (GO:0031652) | 2.73669502 |
| 60 | regulation of fever generation (GO:0031620) | 2.72402826 |
| 61 | cytidine deamination (GO:0009972) | 2.72041490 |
| 62 | cytidine metabolic process (GO:0046087) | 2.72041490 |
| 63 | cytidine catabolic process (GO:0006216) | 2.72041490 |
| 64 | regulation of macrophage differentiation (GO:0045649) | 2.70255005 |
| 65 | positive regulation of leukocyte degranulation (GO:0043302) | 2.66270057 |
| 66 | regulation of monocyte chemotaxis (GO:0090025) | 2.64170889 |
| 67 | localization within membrane (GO:0051668) | 2.64076411 |
| 68 | positive regulation of smooth muscle contraction (GO:0045987) | 2.63935494 |
| 69 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.61962484 |
| 70 | negative regulation by host of viral transcription (GO:0043922) | 2.61396183 |
| 71 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.60921017 |
| 72 | regulation of vitamin metabolic process (GO:0030656) | 2.60854813 |
| 73 | positive regulation of macrophage differentiation (GO:0045651) | 2.59894697 |
| 74 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.59612621 |
| 75 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.59612621 |
| 76 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.59417725 |
| 77 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.59417725 |
| 78 | regulation of chemokine secretion (GO:0090196) | 2.57650059 |
| 79 | protein neddylation (GO:0045116) | 2.56922371 |
| 80 | cyclooxygenase pathway (GO:0019371) | 2.55820235 |
| 81 | response to xenobiotic stimulus (GO:0009410) | 2.54461510 |
| 82 | regulation of alkaline phosphatase activity (GO:0010692) | 2.54336077 |
| 83 | DNA deamination (GO:0045006) | 2.51328793 |
| 84 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.51274392 |
| 85 | regulation of transmission of nerve impulse (GO:0051969) | 2.50360529 |
| 86 | Golgi to plasma membrane protein transport (GO:0043001) | 2.48503353 |
| 87 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.47643086 |
| 88 | iron-sulfur cluster assembly (GO:0016226) | 2.45870579 |
| 89 | metallo-sulfur cluster assembly (GO:0031163) | 2.45870579 |
| 90 | positive regulation of interleukin-17 production (GO:0032740) | 2.44269203 |
| 91 | positive regulation of type 2 immune response (GO:0002830) | 2.43352941 |
| 92 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.40701742 |
| 93 | positive regulation of positive chemotaxis (GO:0050927) | 2.39991051 |
| 94 | mesodermal cell differentiation (GO:0048333) | 2.39662059 |
| 95 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.39465622 |
| 96 | intracellular pH reduction (GO:0051452) | 2.38699628 |
| 97 | polyamine biosynthetic process (GO:0006596) | 2.38404394 |
| 98 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.38240252 |
| 99 | positive regulation of p38MAPK cascade (GO:1900745) | 2.36251152 |
| 100 | regulation of interleukin-17 production (GO:0032660) | 2.35533306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.61757720 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.48475431 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.09717947 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.91729844 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.88464046 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.82083807 |
| 7 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.74758827 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.64710823 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52110350 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.46722716 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.38127196 |
| 12 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.31719109 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28554095 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.27301866 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22212242 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.19751587 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19284297 |
| 18 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.15101630 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11152506 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10928894 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.06027123 |
| 22 | CJUN_26792858_Chip-Seq_BT549_Human | 2.04161156 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02017527 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96890988 |
| 25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89436446 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86962195 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86929773 |
| 28 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.80106238 |
| 29 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.75493062 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74716924 |
| 31 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.73236078 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70397114 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.65571334 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64873653 |
| 35 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.63719396 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62306297 |
| 37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.59556124 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57802261 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54431817 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46711351 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44493431 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.41714107 |
| 43 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39334895 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36204103 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33741886 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33195395 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32510456 |
| 48 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.32406806 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29941291 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.25466714 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24885007 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24821484 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24821484 |
| 54 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24590596 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20488958 |
| 56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18379259 |
| 57 | MYB_26560356_Chip-Seq_TH2_Human | 1.18097358 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16396415 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15694916 |
| 60 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.15485490 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.15473419 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15307736 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12420597 |
| 64 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09412492 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09205810 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08469705 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.06391796 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06247280 |
| 69 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06158108 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04466089 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01798755 |
| 72 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01786857 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01786857 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99100617 |
| 75 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.99034953 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98033584 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97021272 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95316391 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94416787 |
| 80 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94146360 |
| 81 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94028699 |
| 82 | NFYB_21822215_ChIP-Seq_K562_Human | 0.93025205 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92106479 |
| 84 | NFYA_21822215_ChIP-Seq_K562_Human | 0.92035478 |
| 85 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.91111618 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89943558 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89410271 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89302449 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88069622 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87022928 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83038973 |
| 92 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.82677782 |
| 93 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.80439415 |
| 94 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.80168318 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 0.79110963 |
| 96 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78925291 |
| 97 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.78598267 |
| 98 | MAF_26560356_Chip-Seq_TH1_Human | 0.78306275 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.78165444 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77930471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.12375845 |
| 2 | MP0006082_CNS_inflammation | 3.00601408 |
| 3 | MP0002254_reproductive_system_inflammat | 3.00138200 |
| 4 | MP0003436_decreased_susceptibility_to | 2.98016933 |
| 5 | MP0009764_decreased_sensitivity_to | 2.93358730 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.93143259 |
| 7 | MP0008004_abnormal_stomach_pH | 2.82023360 |
| 8 | MP0003724_increased_susceptibility_to | 2.74016241 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.69731255 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.63005927 |
| 11 | MP0005671_abnormal_response_to | 2.53433961 |
| 12 | MP0003303_peritoneal_inflammation | 2.52361063 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.35846714 |
| 14 | MP0009785_altered_susceptibility_to | 2.35837526 |
| 15 | MP0000343_altered_response_to | 2.19236365 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.16345717 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.15230716 |
| 18 | MP0003075_altered_response_to | 2.13773004 |
| 19 | MP0006054_spinal_hemorrhage | 2.06280997 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 2.04588743 |
| 21 | MP0004130_abnormal_muscle_cell | 1.92053443 |
| 22 | MP0005165_increased_susceptibility_to | 1.89638551 |
| 23 | MP0003448_altered_tumor_morphology | 1.88930474 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.88116908 |
| 25 | MP0001873_stomach_inflammation | 1.87093614 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.82413168 |
| 27 | MP0003646_muscle_fatigue | 1.76448746 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.75859753 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.71845506 |
| 30 | MP0004510_myositis | 1.69529877 |
| 31 | MP0001853_heart_inflammation | 1.69234120 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.62619012 |
| 33 | MP0002723_abnormal_immune_serum | 1.61477654 |
| 34 | MP0001542_abnormal_bone_strength | 1.59015431 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.53708380 |
| 36 | MP0002419_abnormal_innate_immunity | 1.51760087 |
| 37 | MP0003186_abnormal_redox_activity | 1.50752082 |
| 38 | MP0009840_abnormal_foam_cell | 1.42282341 |
| 39 | MP0009765_abnormal_xenobiotic_induced | 1.41282808 |
| 40 | MP0000858_altered_metastatic_potential | 1.39408173 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.36005372 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.33953240 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.33887332 |
| 44 | MP0001727_abnormal_embryo_implantation | 1.33166012 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.33095881 |
| 46 | MP0003045_fibrosis | 1.32117014 |
| 47 | MP0008469_abnormal_protein_level | 1.29567487 |
| 48 | MP0001790_abnormal_immune_system | 1.27277036 |
| 49 | MP0005387_immune_system_phenotype | 1.27277036 |
| 50 | MP0005166_decreased_susceptibility_to | 1.22806014 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.19855582 |
| 52 | MP0000685_abnormal_immune_system | 1.18707331 |
| 53 | MP0004233_abnormal_muscle_weight | 1.17446553 |
| 54 | MP0001819_abnormal_immune_cell | 1.16530376 |
| 55 | MP0005623_abnormal_meninges_morphology | 1.15728376 |
| 56 | MP0009763_increased_sensitivity_to | 1.15607167 |
| 57 | MP0002405_respiratory_system_inflammati | 1.15558123 |
| 58 | MP0002102_abnormal_ear_morphology | 1.14880838 |
| 59 | MP0005025_abnormal_response_to | 1.13988480 |
| 60 | MP0001800_abnormal_humoral_immune | 1.13233811 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.13230164 |
| 62 | MP0004215_abnormal_myocardial_fiber | 1.13004114 |
| 63 | MP0005410_abnormal_fertilization | 1.11051521 |
| 64 | MP0005023_abnormal_wound_healing | 1.03966968 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.00534153 |
| 66 | MP0002822_catalepsy | 1.00215699 |
| 67 | MP0000750_abnormal_muscle_regeneration | 0.98845672 |
| 68 | MP0005164_abnormal_response_to | 0.97856558 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 0.96076722 |
| 70 | MP0005666_abnormal_adipose_tissue | 0.95860682 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94058313 |
| 72 | MP0001663_abnormal_digestive_system | 0.93269232 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 0.93162917 |
| 74 | MP0001881_abnormal_mammary_gland | 0.92260873 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.91988802 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.91878695 |
| 77 | MP0004036_abnormal_muscle_relaxation | 0.91249880 |
| 78 | MP0002972_abnormal_cardiac_muscle | 0.90754230 |
| 79 | MP0005390_skeleton_phenotype | 0.90601940 |
| 80 | MP0009384_cardiac_valve_regurgitation | 0.89893567 |
| 81 | MP0000627_abnormal_mammary_gland | 0.88330037 |
| 82 | MP0005266_abnormal_metabolism | 0.87827660 |
| 83 | MP0008007_abnormal_cellular_replicative | 0.86466947 |
| 84 | MP0004043_abnormal_pH_regulation | 0.85867975 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.85142693 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.84932380 |
| 87 | MP0003763_abnormal_thymus_physiology | 0.83490941 |
| 88 | MP0009697_abnormal_copulation | 0.82882129 |
| 89 | MP0004947_skin_inflammation | 0.81760892 |
| 90 | MP0002090_abnormal_vision | 0.80961412 |
| 91 | MP0000716_abnormal_immune_system | 0.76621833 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.74902208 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 0.74299200 |
| 94 | MP0005330_cardiomyopathy | 0.74288968 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 0.73082056 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.72443492 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.71779945 |
| 98 | MP0000249_abnormal_blood_vessel | 0.69700508 |
| 99 | MP0002429_abnormal_blood_cell | 0.68753082 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.68239643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.20235319 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.20235319 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.20235319 |
| 4 | Vertebral compression fractures (HP:0002953) | 4.75968862 |
| 5 | Autoamputation (HP:0001218) | 4.63553667 |
| 6 | Aplastic anemia (HP:0001915) | 4.42687954 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.02327395 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.46103924 |
| 9 | Abnormality of proline metabolism (HP:0010907) | 3.41466535 |
| 10 | Hydroxyprolinuria (HP:0003080) | 3.41466535 |
| 11 | Stenosis of the external auditory canal (HP:0000402) | 3.40461312 |
| 12 | Petechiae (HP:0000967) | 3.31664053 |
| 13 | Tetraparesis (HP:0002273) | 3.26393003 |
| 14 | Increased IgM level (HP:0003496) | 3.24661583 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.21764111 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.17306667 |
| 17 | Spondylolisthesis (HP:0003302) | 3.12778889 |
| 18 | Stomatitis (HP:0010280) | 3.12083925 |
| 19 | T lymphocytopenia (HP:0005403) | 3.10454868 |
| 20 | Purpura (HP:0000979) | 3.02086671 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.73941492 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.73941492 |
| 23 | Amyotrophic lateral sclerosis (HP:0007354) | 2.71845906 |
| 24 | Bundle branch block (HP:0011710) | 2.70608608 |
| 25 | Absent frontal sinuses (HP:0002688) | 2.66547933 |
| 26 | Increased intramyocellular lipid droplets (HP:0012240) | 2.65667279 |
| 27 | Abnormality of T cell number (HP:0011839) | 2.60876582 |
| 28 | Increased mean platelet volume (HP:0011877) | 2.58739514 |
| 29 | Abnormality of alanine metabolism (HP:0010916) | 2.51395344 |
| 30 | Hyperalaninemia (HP:0003348) | 2.51395344 |
| 31 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.51395344 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.49966846 |
| 33 | IgG deficiency (HP:0004315) | 2.44357323 |
| 34 | Insidious onset (HP:0003587) | 2.41413192 |
| 35 | Termporal pattern (HP:0011008) | 2.41413192 |
| 36 | Abnormal platelet volume (HP:0011876) | 2.41035601 |
| 37 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.37483528 |
| 38 | Upper limb muscle weakness (HP:0003484) | 2.34090871 |
| 39 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.33723556 |
| 40 | Radial bowing (HP:0002986) | 2.33657188 |
| 41 | Generalized aminoaciduria (HP:0002909) | 2.30368334 |
| 42 | Myocardial infarction (HP:0001658) | 2.30011117 |
| 43 | Increased serum ferritin (HP:0003281) | 2.29016596 |
| 44 | Increased muscle lipid content (HP:0009058) | 2.28916375 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.28740040 |
| 46 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22314659 |
| 47 | Hepatocellular necrosis (HP:0001404) | 2.19705583 |
| 48 | Renal Fanconi syndrome (HP:0001994) | 2.17558485 |
| 49 | Mutism (HP:0002300) | 2.12687023 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.12270185 |
| 51 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.10205428 |
| 52 | Disinhibition (HP:0000734) | 2.09308208 |
| 53 | Menorrhagia (HP:0000132) | 2.09134802 |
| 54 | Prolonged neonatal jaundice (HP:0006579) | 2.07441259 |
| 55 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.04082089 |
| 56 | Upper motor neuron abnormality (HP:0002127) | 2.01428138 |
| 57 | Supraventricular tachycardia (HP:0004755) | 2.01155873 |
| 58 | Metaphyseal dysplasia (HP:0100255) | 2.00960865 |
| 59 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.97947093 |
| 60 | Neonatal hypoglycemia (HP:0001998) | 1.96262195 |
| 61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95817120 |
| 62 | Abnormality of the costochondral junction (HP:0000919) | 1.94977766 |
| 63 | Mitochondrial inheritance (HP:0001427) | 1.94868585 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 1.94186841 |
| 65 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.93071951 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 1.91450652 |
| 67 | Failure to thrive in infancy (HP:0001531) | 1.91207143 |
| 68 | Abnormality of iron homeostasis (HP:0011031) | 1.91102922 |
| 69 | Primary atrial arrhythmia (HP:0001692) | 1.90910617 |
| 70 | Cutaneous melanoma (HP:0012056) | 1.89515498 |
| 71 | Left ventricular hypertrophy (HP:0001712) | 1.88486088 |
| 72 | Supraventricular arrhythmia (HP:0005115) | 1.88130075 |
| 73 | Loss of speech (HP:0002371) | 1.85006674 |
| 74 | Hepatosplenomegaly (HP:0001433) | 1.84451829 |
| 75 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83191858 |
| 76 | Entropion (HP:0000621) | 1.82763897 |
| 77 | Abnormal neuron morphology (HP:0012757) | 1.82501342 |
| 78 | Abnormality of the motor neurons (HP:0002450) | 1.82501342 |
| 79 | Hypoproteinemia (HP:0003075) | 1.82337411 |
| 80 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.82282303 |
| 81 | Atrial fibrillation (HP:0005110) | 1.82191719 |
| 82 | Achilles tendon contracture (HP:0001771) | 1.82009273 |
| 83 | Flared iliac wings (HP:0002869) | 1.81939795 |
| 84 | Axonal loss (HP:0003447) | 1.81680849 |
| 85 | Hypoalbuminemia (HP:0003073) | 1.81021087 |
| 86 | Abnormal albumin level (HP:0012116) | 1.81021087 |
| 87 | Hepatic necrosis (HP:0002605) | 1.79551641 |
| 88 | Increased CSF lactate (HP:0002490) | 1.78880281 |
| 89 | Abolished electroretinogram (ERG) (HP:0000550) | 1.78486131 |
| 90 | Acute hepatic failure (HP:0006554) | 1.75987695 |
| 91 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75147037 |
| 92 | Episodic fever (HP:0001954) | 1.72693065 |
| 93 | Fasciculations (HP:0002380) | 1.72666140 |
| 94 | Palpitations (HP:0001962) | 1.68952243 |
| 95 | Abnormality of the frontal sinuses (HP:0002687) | 1.67385039 |
| 96 | Zonular cataract (HP:0010920) | 1.66608178 |
| 97 | Bicuspid aortic valve (HP:0001647) | 1.66128573 |
| 98 | Combined immunodeficiency (HP:0005387) | 1.66049617 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 1.65390649 |
| 100 | 3-Methylglutaconic aciduria (HP:0003535) | 1.64678289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.99764831 |
| 2 | TESK2 | 3.68961927 |
| 3 | LIMK1 | 3.03647444 |
| 4 | BMPR2 | 3.02641187 |
| 5 | KDR | 2.98529872 |
| 6 | EIF2AK1 | 2.91913271 |
| 7 | MYLK | 2.76546792 |
| 8 | TESK1 | 2.62146862 |
| 9 | MAP3K12 | 2.56577354 |
| 10 | ILK | 2.44110828 |
| 11 | CAMKK2 | 2.37289700 |
| 12 | TXK | 2.15705442 |
| 13 | TTN | 2.10442614 |
| 14 | ERBB3 | 2.08791683 |
| 15 | PIM2 | 2.04420576 |
| 16 | CDK19 | 2.01847839 |
| 17 | CDK8 | 1.92312472 |
| 18 | TRIB3 | 1.88831899 |
| 19 | SCYL2 | 1.87713859 |
| 20 | GRK7 | 1.81562200 |
| 21 | TBK1 | 1.75310095 |
| 22 | TAOK2 | 1.70463158 |
| 23 | DMPK | 1.66024657 |
| 24 | NME2 | 1.63954250 |
| 25 | ERBB4 | 1.61872686 |
| 26 | MST1R | 1.60479101 |
| 27 | PDK2 | 1.48747505 |
| 28 | DYRK3 | 1.39240827 |
| 29 | CDK9 | 1.36256612 |
| 30 | ADRBK2 | 1.36231613 |
| 31 | EPHB2 | 1.33200802 |
| 32 | BCKDK | 1.30514458 |
| 33 | MAP3K11 | 1.30315858 |
| 34 | PKN1 | 1.18451798 |
| 35 | BRSK2 | 1.13009005 |
| 36 | TEC | 1.09501715 |
| 37 | PTK2 | 1.06413386 |
| 38 | BCR | 1.05140651 |
| 39 | DAPK3 | 1.02261177 |
| 40 | CAMK2B | 0.96740864 |
| 41 | IKBKB | 0.96355652 |
| 42 | LATS2 | 0.89656806 |
| 43 | MAP3K5 | 0.88633341 |
| 44 | CAMK2D | 0.86885617 |
| 45 | ZAP70 | 0.86329240 |
| 46 | BMX | 0.85632206 |
| 47 | SYK | 0.85329705 |
| 48 | PAK6 | 0.82994548 |
| 49 | MST4 | 0.78371882 |
| 50 | MAP2K7 | 0.78034649 |
| 51 | PINK1 | 0.77102760 |
| 52 | PAK1 | 0.76635687 |
| 53 | ABL2 | 0.76240980 |
| 54 | PRKCE | 0.73968325 |
| 55 | TGFBR2 | 0.72583519 |
| 56 | CAMK2G | 0.72271307 |
| 57 | CSK | 0.71382856 |
| 58 | EIF2AK3 | 0.70496883 |
| 59 | IRAK4 | 0.67030438 |
| 60 | DYRK1B | 0.66509801 |
| 61 | MAPKAPK3 | 0.65404153 |
| 62 | MAP3K4 | 0.61980601 |
| 63 | PAK3 | 0.59403370 |
| 64 | SIK3 | 0.58670786 |
| 65 | PAK4 | 0.56994529 |
| 66 | PAK2 | 0.55331203 |
| 67 | CDC7 | 0.54827911 |
| 68 | BTK | 0.54646855 |
| 69 | MARK3 | 0.50351743 |
| 70 | PRKD1 | 0.50069504 |
| 71 | JAK3 | 0.48756935 |
| 72 | MET | 0.48732364 |
| 73 | LCK | 0.48467791 |
| 74 | CHUK | 0.44824346 |
| 75 | ITK | 0.44698846 |
| 76 | RPS6KA4 | 0.44434053 |
| 77 | PTK2B | 0.43876835 |
| 78 | CSF1R | 0.43774217 |
| 79 | MAP4K2 | 0.43525822 |
| 80 | CAMK2A | 0.43130425 |
| 81 | TAOK3 | 0.41990663 |
| 82 | ROCK2 | 0.40269850 |
| 83 | GRK5 | 0.39979892 |
| 84 | INSR | 0.39507804 |
| 85 | MAP4K1 | 0.39464249 |
| 86 | ROCK1 | 0.39142832 |
| 87 | MAP3K7 | 0.36931350 |
| 88 | PRKCD | 0.36092823 |
| 89 | TIE1 | 0.35850688 |
| 90 | PDGFRB | 0.35596767 |
| 91 | MATK | 0.35273733 |
| 92 | AKT3 | 0.33022040 |
| 93 | DAPK1 | 0.32145947 |
| 94 | RPS6KA5 | 0.31855113 |
| 95 | CSNK1G3 | 0.31837568 |
| 96 | NEK1 | 0.31161119 |
| 97 | PLK2 | 0.30717412 |
| 98 | CDK14 | 0.29256155 |
| 99 | NEK9 | 0.28303560 |
| 100 | SIK2 | 0.28244600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.17342913 |
| 2 | Salmonella infection_Homo sapiens_hsa05132 | 2.99583884 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.46998960 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.39904683 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.39556698 |
| 6 | Shigellosis_Homo sapiens_hsa05131 | 2.31201186 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.28326206 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.21403725 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.15183195 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.13243504 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.06939501 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06491755 |
| 13 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.01946517 |
| 14 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.99782530 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.89013201 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82288697 |
| 17 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.77684613 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61039132 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60791345 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.59437195 |
| 21 | Proteasome_Homo sapiens_hsa03050 | 1.57697714 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.57369138 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56857281 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.56841094 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56821531 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55275615 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.54378134 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49668593 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.45953803 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44902933 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36654937 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.35542770 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35158621 |
| 34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.34986424 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.34397195 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.33274127 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32464489 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32406062 |
| 39 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.30387654 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26327241 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17343804 |
| 42 | Endocytosis_Homo sapiens_hsa04144 | 1.17211315 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.14125088 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.13841335 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13080637 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.10902990 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10357721 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07701822 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05126891 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96665245 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.94880219 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93949995 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 0.93112890 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.87497957 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.87445555 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86712069 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81672566 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79907564 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77517132 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76678649 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76671487 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.73351235 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72943822 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71731772 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.71234674 |
| 66 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70349146 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68541143 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68411840 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.68355841 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67602645 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67069210 |
| 72 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63485679 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59683046 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.56915643 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51813876 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.48541731 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47792855 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45944677 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41877154 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.41582717 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41545837 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40469121 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38425375 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37010491 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36613954 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.36158599 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.35679859 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34082155 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32375772 |
| 90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.29375187 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27939949 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.26320107 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25876852 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23018291 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.22292878 |
| 96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22288092 |
| 97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.21472591 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20113841 |
| 99 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19045198 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.17936772 |

